Study of Safety and Efficacy of BCD-020 Comparing to MabThera in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove that efficacy, safety and immunogenicity of BCD-020 is
equivalent to MabThera when used in combination with methotrexate for the treatment of
patient with rheumatoid arthritis